ID   P2RX5_RAT               Reviewed;         455 AA.
AC   P51578; A6HGI1; G3V8I0; Q64613;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   29-MAY-2024, sequence version 2.
DT   02-OCT-2024, entry version 143.
DE   RecName: Full=P2X purinoceptor 5;
DE            Short=P2X5;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=Purinergic receptor;
GN   Name=P2rx5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND ACTIVITY REGULATION.
RC   TISSUE=Coeliac ganglion;
RX   PubMed=8786426; DOI=10.1523/jneurosci.16-08-02495.1996;
RA   Collo G., Kawashima E., Pich E., Neidhart S., North R.A., Surprenant A.,
RA   Buell G.N.;
RT   "Cloning of P2X5 and P2X6 receptors and the distribution and properties of
RT   an extended family of ATP-gated ion channels.";
RL   J. Neurosci. 16:2495-2507(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND ACTIVITY
RP   REGULATION.
RC   STRAIN=Sprague-Dawley; TISSUE=Heart;
RX   PubMed=8690069; DOI=10.1016/0014-5793(96)00499-1;
RA   Garcia-Guzman M., Soto F., Laube B., Stuehmer W.;
RT   "Molecular cloning and functional expression of a novel rat heart P2X
RT   purinoceptor.";
RL   FEBS Lett. 388:123-127(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Li P.W., Adams M.D., Amanatides P.G., Baden-Tillson H.,
RA   Barnstead M., Chin S.H., Dew I., Evans C.A., Ferriera S., Flanigan M.,
RA   Fosler C., Glodek A., Gu Z., Holt R.A., Jennings D., Kraft C.L., Lu F.,
RA   Nguyen T., Nusskern D.R., Pfannkoch C.M., Sitter C., Sutton G.G.,
RA   Venter J.C., Wang Z., Woodage T., Zheng X.H., Zhong F.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   SUBUNIT, AND INTERACTION WITH P2RX1.
RX   PubMed=9855626; DOI=10.1124/mol.54.6.989;
RA   Torres G.E., Haines W.R., Egan T.M., Voigt M.M.;
RT   "Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated
RT   ion channel.";
RL   Mol. Pharmacol. 54:989-993(1998).
RN   [6]
RP   SUBUNIT, AND INTERACTION WITH P2RX1.
RX   PubMed=10336430; DOI=10.1074/jbc.274.22.15415;
RA   Le K.T., Boue-Grabot E., Archambault V., Seguela P.;
RT   "Functional and biochemical evidence for heteromeric ATP-gated channels
RT   composed of P2X1 and P2X5 subunits.";
RL   J. Biol. Chem. 274:15415-15419(1999).
RN   [7]
RP   SUBUNIT.
RX   PubMed=17001079; DOI=10.1074/jbc.m606113200;
RA   Duckwitz W., Hausmann R., Aschrafi A., Schmalzing G.;
RT   "P2X5 subunit assembly requires scaffolding by the second transmembrane
RT   domain and a conserved aspartate.";
RL   J. Biol. Chem. 281:39561-39572(2006).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF VAL-67 AND PHE-195.
RX   PubMed=31727741; DOI=10.1074/jbc.ra119.009959;
RA   Sun L.F., Liu Y., Wang J., Huang L.D., Yang Y., Cheng X.Y., Fan Y.Z.,
RA   Zhu M.X., Liang H., Tian Y., Wang H.S., Guo C.R., Yu Y.;
RT   "Altered allostery of the left flipper domain underlies the weak ATP
RT   response of rat P2X5 receptors.";
RL   J. Biol. Chem. 294:19589-19603(2019).
CC   -!- FUNCTION: ATP-gated nonselective transmembrane cation channel
CC       (PubMed:8786426). Permeable to potassium, sodium and calcium (By
CC       similarity). Unlike, other P2RX receptors, the P2X5 receptor is also
CC       permeable to chloride (By similarity). Acts as an important regulator
CC       of inflammatory-related bone loss and osteoclast multinucleation (By
CC       similarity). {ECO:0000250|UniProtKB:Q91VE2,
CC       ECO:0000250|UniProtKB:Q93086, ECO:0000269|PubMed:8786426}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(in) = Na(+)(out); Xref=Rhea:RHEA:34963,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000250|UniProtKB:Q93086};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Ca(2+)(in) = Ca(2+)(out); Xref=Rhea:RHEA:29671,
CC         ChEBI:CHEBI:29108; Evidence={ECO:0000250|UniProtKB:Q93086};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chloride(in) = chloride(out); Xref=Rhea:RHEA:29823,
CC         ChEBI:CHEBI:17996; Evidence={ECO:0000250|UniProtKB:Q93086};
CC   -!- ACTIVITY REGULATION: Activated by ATP (PubMed:8690069, PubMed:8786426).
CC       Slowly desensitizing (PubMed:8786426). Not activated by ATP
CC       agonist:alpha/beta-methylene-ATP (PubMed:8690069, PubMed:8786426).
CC       Highly sensitives to the antagonists suramin and PPADS (PubMed:8690069,
CC       PubMed:8786426). {ECO:0000269|PubMed:8690069,
CC       ECO:0000269|PubMed:8786426}.
CC   -!- SUBUNIT: Functional P2XRs are organized as homomeric and heteromeric
CC       trimers. Homotrimers (PubMed:17001079). Forms hererotrimer wth P2RX1
CC       (PubMed:10336430, PubMed:9855626). {ECO:0000269|PubMed:10336430,
CC       ECO:0000269|PubMed:17001079, ECO:0000269|PubMed:9855626}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q93086};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P56373}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in heart but are also
CC       present in brain, spinal cord and adrenal gland.
CC       {ECO:0000269|PubMed:8690069}.
CC   -!- DOMAIN: The second transmembrane domain and the conserved Asp-355 are
CC       essential for P2RX5 subunit assembly. {ECO:0000250|UniProtKB:Q93086}.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X92069; CAA63052.1; -; mRNA.
DR   EMBL; X97328; CAA65993.1; -; mRNA.
DR   EMBL; AC126839; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473948; EDM05136.1; -; Genomic_DNA.
DR   PIR; S71344; S71344.
DR   RefSeq; NP_542958.2; NM_080780.2.
DR   AlphaFoldDB; P51578; -.
DR   SMR; P51578; -.
DR   STRING; 10116.ENSRNOP00000026156; -.
DR   BindingDB; P51578; -.
DR   ChEMBL; CHEMBL2495; -.
DR   DrugCentral; P51578; -.
DR   GuidetoPHARMACOLOGY; 482; -.
DR   GlyCosmos; P51578; 3 sites, No reported glycans.
DR   GlyGen; P51578; 3 sites.
DR   PhosphoSitePlus; P51578; -.
DR   PaxDb; 10116-ENSRNOP00000026156; -.
DR   Ensembl; ENSRNOT00000026156.6; ENSRNOP00000026156.2; ENSRNOG00000019208.8.
DR   GeneID; 113995; -.
DR   KEGG; rno:113995; -.
DR   AGR; RGD:620256; -.
DR   CTD; 5026; -.
DR   RGD; 620256; P2rx5.
DR   eggNOG; ENOG502QSUI; Eukaryota.
DR   GeneTree; ENSGT01020000230351; -.
DR   HOGENOM; CLU_034469_2_0_1; -.
DR   InParanoid; P51578; -.
DR   OMA; QKHHITF; -.
DR   OrthoDB; 5312692at2759; -.
DR   PhylomeDB; P51578; -.
DR   Reactome; R-RNO-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-RNO-418346; Platelet homeostasis.
DR   PRO; PR:P51578; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Proteomes; UP000234681; Chromosome 10.
DR   Bgee; ENSRNOG00000019208; Expressed in heart and 12 other cell types or tissues.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0035381; F:ATP-gated ion channel activity; IDA:UniProtKB.
DR   GO; GO:0004931; F:extracellularly ATP-gated monoatomic cation channel activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0099095; F:ligand-gated monoatomic anion channel activity; ISS:UniProtKB.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IEA:InterPro.
DR   GO; GO:0005244; F:voltage-gated monoatomic ion channel activity; IDA:RGD.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006821; P:chloride transport; ISS:UniProtKB.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0098655; P:monoatomic cation transmembrane transport; IDA:RGD.
DR   GO; GO:0006812; P:monoatomic cation transport; TAS:RGD.
DR   GO; GO:0036179; P:osteoclast maturation; ISS:UniProtKB.
DR   GO; GO:1905665; P:positive regulation of calcium ion import across plasma membrane; IDA:RGD.
DR   GO; GO:0043416; P:regulation of skeletal muscle tissue regeneration; IMP:RGD.
DR   GO; GO:0033198; P:response to ATP; IDA:RGD.
DR   GO; GO:0051592; P:response to calcium ion; IDA:RGD.
DR   GO; GO:0009268; P:response to pH; IDA:RGD.
DR   GO; GO:0010043; P:response to zinc ion; IDA:RGD.
DR   GO; GO:0048630; P:skeletal muscle tissue growth; TAS:RGD.
DR   Gene3D; 1.10.287.940; atp-gated p2x4 ion channel; 1.
DR   Gene3D; 2.60.490.10; atp-gated p2x4 ion channel domain; 1.
DR   InterPro; IPR003048; P2X5_purnocptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   InterPro; IPR053792; P2X_RECEPTOR_CS.
DR   NCBIfam; TIGR00863; P2X; 1.
DR   PANTHER; PTHR10125; P2X PURINOCEPTOR; 1.
DR   PANTHER; PTHR10125:SF12; P2X PURINOCEPTOR 5; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PIRSF; PIRSF005713; P2X_purinoceptor; 1.
DR   PRINTS; PR01312; P2X5RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Receptor; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..455
FT                   /note="P2X purinoceptor 5"
FT                   /id="PRO_0000161556"
FT   TOPO_DOM        1..34
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        35..55
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   TOPO_DOM        56..341
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        342..362
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   TOPO_DOM        363..455
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REGION          384..422
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        384..410
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         69
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   BINDING         71
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   BINDING         189
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   BINDING         294
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   BINDING         296
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   BINDING         314
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   CARBOHYD        77
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        157
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        202
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        118..169
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   DISULFID        129..152
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   DISULFID        135..163
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   DISULFID        220..229
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   DISULFID        263..272
FT                   /evidence="ECO:0000250|UniProtKB:F8W463"
FT   MUTAGEN         67
FT                   /note="V->I: Increases the ATP-evoked response."
FT                   /evidence="ECO:0000269|PubMed:31727741"
FT   MUTAGEN         195
FT                   /note="F->H: Increases the ATP-evoked response."
FT                   /evidence="ECO:0000269|PubMed:31727741"
FT   CONFLICT        191
FT                   /note="F -> S (in Ref. 1; CAA63052)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        396
FT                   /note="R -> Q (in Ref. 2; CAA65993)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   455 AA;  51539 MW;  D0101EE44B49BF70 CRC64;
     MGQAAWKGFV LSLFDYKTAK FVVAKSKKVG LLYRVLQLII LLYLLIWVFL IKKSYQDIDT
     SLQSAVVTKV KGVAYTNTTM LGERLWDVAD FVIPSQGENV FFVVTNLIVT PNQRQGICAE
     REGIPDGECS EDDDCHAGES VVAGHGLKTG RCLRVGNSTR GTCEIFAWCP VETKSMPTDP
     LLKDAESFTI FIKNFIRFPK FNFSKANVLE TDNKHFLKTC HFSSTNLYCP IFRLGSIVRW
     AGADFQDIAL KGGVIGIYIE WDCDLDKAAS KCNPHYYFNR LDNKHTHSIS SGYNFRFARY
     YRDPNGVEFR DLMKAYGIRF DVIVNGKAGK FSIIPTVINI GSGLALMGAG AFFCDLVLIY
     LIRKSEFYRD KKFEKVRGQK EDANVEVEAN EMEQERPEDE PLERVRQDEQ SQELAQSGRK
     QNSNCQVLLE PARFGLRENA IVNVKQSQIL HPVKT
//
